TipRanks
Go Ultimate55% OFF

Akzo Nobel (AKUP) AI Stock Analysis

DE:AKUP

Akzo Nobel

(Frankfurt:AKUP)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Pricing Power and Margin ExpansionSustained pricing execution has more than offset raw-material inflation and supported six consecutive quarters of margin expansion. This indicates differentiated commercial capability and improving operating discipline, helping protect profitability even while volumes remain under pressure.
Negative Factors
Structural Revenue ContractionThe sharp TTM revenue decline raises concern that recent profitability improvements may not be durable without a demand recovery. A smaller top line can reduce operating leverage, limit reinvestment capacity and make it harder to sustain earnings growth across the next several quarters.

Akzo Nobel (AKUP) vs. iShares MSCI Germany ETF (EWG)

-20%-10%0%10%20%30%DE:AKUP+9.39%EWG+4.43%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
EUR 34.02B
Dividend Yield
3.36%
Average Volume (3M)
3
Price to Earnings (P/E)
15.6
Beta (1Y)
1.02
Revenue Growth
-5.00%
EPS Growth
1020.11%
Country
Germany
Employees
31,500
Sector
Basic Materials
Sector Strength
61
Industry
Chemicals - Specialty

Akzo Nobel Business Overview & Revenue Model

Company Description

Akzo Nobel N.V. operates as an international corporation, specializing in the creation, production, and distribution of a comprehensive array of paints and protective surface coverings. The company's offerings fall into two primary categories: decora...

Akzo Nobel Earnings Call Summary

Earnings Call Date:Oct 20, 2026(Q3-2026)|% Change Since:0.52%|Next Earnings Date:Feb 09, 2027
Earnings Call SentimentPositive

The call was predominantly positive. AkzoNobel reported organic sales growth, continued pricing execution, six consecutive quarters of margin expansion, improved working capital, lower leverage, strong value realization from portfolio disposals, and maintained its 2026 EBITDA outlook. These achievements were partly offset by lower volumes, challenging automotive, construction and China markets, high single-digit raw material inflation, transaction-related cash outflows, and pending regulatory clearances for the Axanzo merger.

Positive Updates

Organic Sales Growth and Margin Expansion
Q3 organic sales increased 2%, supported by strong pricing of plus 5%, while adjusted EBITDA rose EUR 15 million to EUR 388 million at comparable scope and constant currencies. The adjusted EBITDA margin increased 20 basis points year-on-year to 15.3%, marking the sixth consecutive quarter of margin expansion.

Negative Updates

Volumes Declined Year-on-Year
Q3 volumes decreased 2% year-on-year, including a 2% decline in Coatings and a 3% decline in Paints. Year-to-date volumes were down 1%.

Company Guidance

AkzoNobel continues to expect 2026 adjusted EBITDA of around EUR 1.47 billion; for Q4, volumes are forecasted to be flat, pricing is expected to be a slight net positive against raw material inflation, and OpEx savings will be delivered as per plan. Pricing will continue to fully offset the inflation currently seen and go further if required, including into next year; raw material inflation was high single digits up in Q3, with a similar trend expected in Q4. The Axanzo value case remains $600 million of cost synergies, around 90% within 3 years of closing, and 100 to 200 basis points of revenue synergy uplift, with closing remaining on track for early 2027.

Akzo Nobel Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

DE:AKUP against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
RPMRPM72Outperform$13.06B18.8621.13%2.14%5.96%0.68%
AXTAAXTA72Outperform$7.29B21.8413.48%―0.14%-25.40%
SHWSHW69Neutral$80.35B30.2963.49%0.96%7.03%5.95%
PPGPPG62Neutral$26.40B16.9819.05%2.40%6.39%27.29%
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
ASHASH56Neutral$3.42B65.512.77%2.24%-1.39%―

* Basic Materials Sector Average

Performance Comparison

0%20%40%60%DE:AKUPASHPPGRPMSHWAXTADec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
DE:AKUP and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:AKUPAkzo Nobel19.401.186.46%
ASHAshland Global Holdings, Inc.74.6827.7659.17%
PPGPpg Industries, Inc.119.5226.9829.16%
RPMRPM International102.44-3.61-3.41%
SHWSherwin-Williams332.61-9.78-2.86%
AXTAAxalta Coating Systems34.075.9721.25%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.